rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Neil W. Gibson

Director

Company insider

Files Form 4 as: Director, Instil Bio; Director, Shattuck Labs; Director, Tcr2 Therapeutics; Chief Scientific Officer, Regulus Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
94
Buys
0
Sells
20
Bought
$0
Sold
$2.5M
Companies
4
Companies where not an officer
3
First trade
11 Dec 2012
Last trade
11 Jun 2026
Last filed
12 Jun 2026

Companies traded

Where they are an officer
Regulus TherapeuticsOfficer · last 28 Jan 20150 buys · 14 sells
Everywhere else they filed: board seats, 10% stakes, other companies
TIL Instil BioDirector · Biotechnology · last 11 Jun 20260 buys · 0 sells
STTK Shattuck LabsDirector · Biotechnology · last 29 May 20260 buys · 0 sells
Tcr2 TherapeuticsDirector · last 1 Jun 20230 buys · 6 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 12 Jun 2026TIL Instil Biooption or derivative · BiotechnologySEC FORM 4 Code A—0 at $0.00filing
11 Jun 2026filed 12 Jun 2026TIL Instil Biooption or derivative · BiotechnologySEC FORM 4 Code A—0 at $0.00filing
29 May 2026filed 2 Jun 2026STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—81,000 at $0.00filing
29 May 2026filed 2 Jun 2026STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—81,000 at $0.00filing
14 Jul 2025filed 16 Jul 2025STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—33,150 at $0.00filing
28 May 2025filed 29 May 2025TIL Instil Biooption or derivative · BiotechnologySEC FORM 4 Code A—6,500 at $0.00filing
21 Jun 2024filed 21 Jun 2024STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—27,700 at $0.00filing
13 Jun 2024filed 13 Jun 2024TIL Instil Biooption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
14 Jun 2023filed 10 Jan 2024TIL Instil Biooption or derivative · BiotechnologySEC FORM 4 Code A—1,500 at $0.00filing
1 Jun 2023filed 1 Jun 2023Tcr2 Therapeuticsoption or derivativeSEC FORM 4 Code D—16,800 at $0.00filing
1 Jun 2023filed 1 Jun 2023Tcr2 Therapeuticsoption or derivativeSEC FORM 4 Code D—6,270 at $0.00filing
1 Jun 2023filed 1 Jun 2023Tcr2 Therapeuticsoption or derivativeSEC FORM 4 Code D—5,000 at $0.00filing
1 Jun 2023filed 1 Jun 2023Tcr2 Therapeuticsoption or derivativeSEC FORM 4 Code D—12,100 at $0.00filing
1 Jun 2023filed 1 Jun 2023Tcr2 Therapeuticsoption or derivativeSEC FORM 4 Code D—12,100 at $0.00filing
1 Jun 2023filed 1 Jun 2023Tcr2 Therapeuticsoption or derivativeSEC FORM 4 Code D—8,072 at $0.00filing
26 May 2023filed 31 May 2023STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—40,258 at $0.00filing
8 Jun 2022filed 10 Jun 2022STTK Shattuck Labsoption or derivative · BiotechnologySEC FORM 4 Code A—40,258 at $0.00filing
20 May 2022filed 25 May 2022TIL Instil Biooption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
9 Dec 2021filed 19 Dec 2022Tcr2 Therapeuticsoption or derivativeSEC FORM 4 Code A—16,800 at $0.00filing
9 Dec 2021filed 10 Dec 2021Tcr2 Therapeuticsoption or derivativeSEC FORM 4 Code A—12,100 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed20

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.